Evidence map›Paper›PMID 18643869›Full record

ArticleJournal of neurochemistry2008

GISP binding to TSG101 increases GABA receptor stability by down-regulating ESCRT-mediated lysosomal degradation.

Sriharsha Kantamneni, David Holman, Kevin A Wilkinson, Sônia A L Corrêa, Marco Feligioni, Simon Ogden, William Fraser, Atsushi Nishimune, Jeremy M Henley

Open access · greenAbstract read
In one paragraph

Article in Journal of neurochemistry, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Ectopic activation of GABANature ecology & evolution · 2021
    Article
  3. Article
  4. CaMolecular neurobiology · 2019
    Article
  5. Article
  6. Regulation of GPCR Trafficking by Ubiquitin.Progress in molecular biology and translational science · 2015
    Review
  7. Review
  8. Article
  9. Article
  10. Neuronal Functions of ESCRTs.Experimental neurobiology · 2012
    Article
  11. Shaping development with ESCRTs.Nature cell biology · 2011
    Review
  12. Article
  13. Activity-dependent SUMOylation of the brain-specific scaffolding protein GISP.Biochemical and biophysical research communications · 2011
    Article
  14. Frontotemporal dementia caused by CHMP2B mutations.Current Alzheimer research · 2011
    Review
  15. The ESCRT complexes.Critical reviews in biochemistry and molecular biology · 2010
    Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Sriharsha KantamneniDepartment of Anatomy, MRC Centre for Synaptic Plasticity, School of Medical Sciences, University of Bristol, Bristol, UK.
David Holman
Kevin A Wilkinson
Sônia A L Corrêa
Marco Feligioni
Simon Ogden
William Fraser
Atsushi Nishimune
Jeremy M Henley
University of Bristol · GB

Funding

Medical Research Council G0601810Wellcome Trust 074017Wellcome Trust 083721
6 · The paper itself

Abstract

The neuron-specific G protein-coupled receptor interacting scaffold protein (GISP) is a multidomain, brain-specific protein derived from the A-kinase anchoring protein-9 gene. We originally isolated GISP as an interacting partner for the GABA(B) receptor subunit GABA(B1). Here, we show that the protein tumour susceptibility gene 101 (TSG101), an integral component of the endosomal sorting machinery that targets membrane proteins for lysosomal degradation, also interacts with GISP. TSG101 co-immunoprecipitates with GISP from adult rat brain, and using GST pull-downs, we identified that the eighth coiled-coiled region of GISP is critical for TSG101 association. Intriguingly, although there is no direct interaction between GISP and the GABA(B2) subunit, their co-expression in HEK293 cells increases levels of GABA(B2). GISP also inhibits TSG101-dependent GABA(B2) down-regulation in human embryonic kidney 293 cells whereas over-expression of a mutant GISP lacking the TSG101 binding domain has no effect on GABA(B2) degradation. These data suggest that GISP can function as a negative regulator of TSG101-dependent lysosomal degradation of transmembrane proteins in neurons to promote receptor stability.

Indexed as

A Kinase Anchor ProteinsAnimalsBrainCell LineCells, CulturedCytoskeletal ProteinsDNA-Binding ProteinsDown-RegulationEndosomal Sorting Complexes Required for TransportEndosomesgamma-Aminobutyric AcidHumansLysosomesMembrane ProteinsMutationNerve Tissue ProteinsAkap9 protein, ratA Kinase Anchor ProteinsCytoskeletal ProteinsDNA-Binding ProteinsEndosomal Sorting Complexes Required for TransportGabbr2 protein, mouseGabrb2 protein, ratgamma-Aminobutyric AcidMembrane ProteinsNerve Tissue ProteinsReceptors, GABA-AReceptors, GABA-BTranscription FactorsTsg101 Protein

Identifiers

PMID18643869
PMCPMC3314514
OpenAlexW2039083191

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.